Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Operating Margin: 2013-2017

Historic Operating Margin for Soleno Therapeutics (SLNO) over the last 3 years, with Jun 2017 value amounting to -296,800.00%.

  • Soleno Therapeutics' Operating Margin fell 18205000.00% to -296,800.00% in Q2 2017 from the same period last year, while for Jun 2017 it was -926.52%, marking a year-over-year increase of 48662.00%. This contributed to the annual value of 81,242.86% for FY2024, which is N/A change from last year.
  • Soleno Therapeutics' Operating Margin amounted to -296,800.00% in Q2 2017, which was down 57,184.78% from -518.11% recorded in Q1 2017.
  • In the past 5 years, Soleno Therapeutics' Operating Margin ranged from a high of 195.07% in Q2 2014 and a low of -296,800.00% during Q2 2017.
  • In the last 3 years, Soleno Therapeutics' Operating Margin had a median value of -1,370.45% in 2015 and averaged -43,117.22%.
  • In the last 5 years, Soleno Therapeutics' Operating Margin skyrocketed by 1,007,358bps in 2016 and then crashed by 18,205,000bps in 2017.
  • Quarterly analysis of 5 years shows Soleno Therapeutics' Operating Margin stood at 180.42% in 2013, then crashed by 10,088bps to 79.54% in 2014, then crashed by 153,178bps to -1,452.24% in 2015, then spiked by 80,629bps to -645.95% in 2016, then plummeted by 18,205,000bps to -296,800.00% in 2017.
  • Its last three reported values are -296,800.00% in Q2 2017, -518.11% for Q1 2017, and -645.95% during Q4 2016.